+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dravet Syndrome Treatment Market 2025-2029- Product Image
Dravet Syndrome Treatment Market 2025-2029- Product Image
New

Dravet Syndrome Treatment Market 2025-2029

  • PDF Icon

    Report

  • 222 Pages
  • May 2025
  • Region: Global
  • TechNavio
  • ID: 5509306
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The dravet syndrome treatment market is forecasted to grow by USD 849.5 million during 2024-2029, accelerating at a CAGR of 11.4% during the forecast period. The report on the dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for ds treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The dravet syndrome treatment market is segmented as below:

By Product

  • SGDs
  • TGDs
  • FGDs

By Diagnostic Methods

  • Magnetic resonance imaging
  • Electroencephalography
  • SCN1A genetic testing
  • Others

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • E-commerce
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increased use of new-generation drugs as one of the prime reasons driving the dravet syndrome treatment market growth during the next few years. Also, advances in biomedical sciences and strong pipeline will lead to sizable demand in the market.

The report on the dravet syndrome treatment market covers the following areas:

  • Dravet Syndrome Treatment Market sizing
  • Dravet Syndrome Treatment Market forecast
  • Dravet Syndrome Treatment Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dravet syndrome treatment market vendors that include AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd. Also, the dravet syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Dravet Syndrome Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Diagnostic Methods segment analysis 2019 - 2023
Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
5.4 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Dravet Syndrome Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 SGDs - Market size and forecast 2024-2029
Chart on SGDs - Market size and forecast 2024-2029 ($ million)
Data Table on SGDs - Market size and forecast 2024-2029 ($ million)
Chart on SGDs - Year-over-year growth 2024-2029 (%)
Data Table on SGDs - Year-over-year growth 2024-2029 (%)
8.4 TGDs - Market size and forecast 2024-2029
Chart on TGDs - Market size and forecast 2024-2029 ($ million)
Data Table on TGDs - Market size and forecast 2024-2029 ($ million)
Chart on TGDs - Year-over-year growth 2024-2029 (%)
Data Table on TGDs - Year-over-year growth 2024-2029 (%)
8.5 FGDs - Market size and forecast 2024-2029
Chart on FGDs - Market size and forecast 2024-2029 ($ million)
Data Table on FGDs - Market size and forecast 2024-2029 ($ million)
Chart on FGDs - Year-over-year growth 2024-2029 (%)
Data Table on FGDs - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Diagnostic Methods
9.1 Market segments
Chart on Diagnostic Methods - Market share 2024-2029 (%)
Data Table on Diagnostic Methods - Market share 2024-2029 (%)
9.2 Comparison by Diagnostic Methods
Chart on Comparison by Diagnostic Methods
Data Table on Comparison by Diagnostic Methods
9.3 Magnetic resonance imaging - Market size and forecast 2024-2029
Chart on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Data Table on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Chart on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
Data Table on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
9.4 Electroencephalography - Market size and forecast 2024-2029
Chart on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Data Table on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Chart on Electroencephalography - Year-over-year growth 2024-2029 (%)
Data Table on Electroencephalography - Year-over-year growth 2024-2029 (%)
9.5 SCN1A genetic testing - Market size and forecast 2024-2029
Chart on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Data Table on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Chart on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
Data Table on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Diagnostic Methods
Market opportunity by Diagnostic Methods ($ million)
Data Table on Market opportunity by Diagnostic Methods ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
10.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
10.3 Hospital pharmacy - Market size and forecast 2024-2029
Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
10.4 Retail pharmacy - Market size and forecast 2024-2029
Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
10.5 E-commerce - Market size and forecast 2024-2029
Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
Chart on E-commerce - Year-over-year growth 2024-2029 (%)
Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 BIOCODEX SAS
BIOCODEX SAS - Overview
BIOCODEX SAS - Product / Service
BIOCODEX SAS - Key offerings
SWOT
15.6 Encoded Therapeutics Inc.
Encoded Therapeutics Inc. - Overview
Encoded Therapeutics Inc. - Product / Service
Encoded Therapeutics Inc. - Key offerings
SWOT
15.7 Epygenix Therapeutics Inc.
Epygenix Therapeutics Inc. - Overview
Epygenix Therapeutics Inc. - Product / Service
Epygenix Therapeutics Inc. - Key offerings
SWOT
15.8 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
SWOT
15.9 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc - Overview
Jazz Pharmaceuticals Plc - Product / Service
Jazz Pharmaceuticals Plc - Key news
Jazz Pharmaceuticals Plc - Key offerings
SWOT
15.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.12 PTC Therapeutics Inc.
PTC Therapeutics Inc. - Overview
PTC Therapeutics Inc. - Product / Service
PTC Therapeutics Inc. - Key offerings
SWOT
15.13 Stoke Therapeutics Inc.
Stoke Therapeutics Inc. - Overview
Stoke Therapeutics Inc. - Product / Service
Stoke Therapeutics Inc. - Key offerings
SWOT
15.14 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.15 Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc. - Overview
Supernus Pharmaceuticals Inc. - Product / Service
Supernus Pharmaceuticals Inc. - Key offerings
SWOT
15.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.17 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibits 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product
Exhibits 41: Data Table on Comparison by Product
Exhibits 42: Chart on SGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on SGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on SGDs - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on SGDs - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on TGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on TGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on TGDs - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on TGDs - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on FGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on FGDs - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on FGDs - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on FGDs - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits 57: Data Table on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Diagnostic Methods
Exhibits 59: Data Table on Comparison by Diagnostic Methods
Exhibits 60: Chart on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Electroencephalography - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Electroencephalography - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 76: Market opportunity by Diagnostic Methods ($ million)
Exhibits 77: Data Table on Market opportunity by Diagnostic Methods ($ million)
Exhibits 78: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 79: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 80: Chart on Comparison by Distribution Channel
Exhibits 81: Data Table on Comparison by Distribution Channel
Exhibits 82: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on E-commerce - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 98: Market opportunity by Distribution Channel ($ million)
Exhibits 99: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 103: Chart on Geographic comparison
Exhibits 104: Data Table on Geographic comparison
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 161: Market opportunity By Geographical Landscape ($ million)
Exhibits 162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 163: Impact of drivers and challenges in 2024 and 2029
Exhibits 164: Overview on criticality of inputs and factors of differentiation
Exhibits 165: Overview on factors of disruption
Exhibits 166: Impact of key risks on business
Exhibits 167: Companies covered
Exhibits 168: Company ranking index
Exhibits 169: Matrix on companies position and classification
Exhibits 170: AbbVie Inc. - Overview
Exhibits 171: AbbVie Inc. - Product / Service
Exhibits 172: AbbVie Inc. - Key news
Exhibits 173: AbbVie Inc. - Key offerings
Exhibits 174: SWOT
Exhibits 175: BIOCODEX SAS - Overview
Exhibits 176: BIOCODEX SAS - Product / Service
Exhibits 177: BIOCODEX SAS - Key offerings
Exhibits 178: SWOT
Exhibits 179: Encoded Therapeutics Inc. - Overview

Executive Summary

The following companies are recognized as the key players in the global dravet syndrome treatment market: AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased use of new-generation drugs."

According to the report, one of the major drivers for this market is the growth in special regulatory designations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • BIOCODEX SAS
  • Encoded Therapeutics Inc.
  • Epygenix Therapeutics Inc.
  • H Lundbeck AS
  • Jazz Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • PTC Therapeutics Inc.
  • Stoke Therapeutics Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Supernus Pharmaceuticals Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • UCB SA
  • Viatris Inc.
  • Xenon Pharmaceuticals Inc.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Dravet Syndrome Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Dravet Syndrome Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 77 Pages
  • Global
From
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024 - Product Image

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • 134 Pages
  • Global
From
Dravet Syndrome Market by Drug Class, End User, Distribution Channel, Route of Administration, Patient Age Group - Global Forecast to 2030 - Product Image

Dravet Syndrome Market by Drug Class, End User, Distribution Channel, Route of Administration, Patient Age Group - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.